Table. Selected epidemiologic and clinical elements from patients with fatal cases of RMSF along the US–Mexico border, 2013–2016*.
Element | Case-patient 1 | Case-patient 2 | Case-patient 3 | Case-patient 4 |
---|---|---|---|---|
Patient history | ||||
Known exposure in RMSF-epidemic area of Mexico | + | + | + | |
Evidence of receipt of medical care in Mexico | + | + | ||
Prescribed nontetracycline antimicrobial drug |
+ |
+ |
+ |
+ |
Signs and symptoms at initial presentation | ||||
Fever | + | + | + | + |
Headache | + | + | ||
Nausea/vomiting/diarrhea | + | + | ||
Rash |
|
|
|
|
Severe end-stage manifestations | ||||
Skin necrosis | + | + | + | |
Rash | + | + | + | + |
Respiratory failure | + | + | + | + |
Disseminated intravascular coagulation | + |
*RMSF, Rocky Mountain spotted fever; +, present; blank cells, absent.